Outlook Therapeutics Inc OTLK:NASDAQ

Last Price$1.57NASDAQ Closing Price as of 4:00PM ET 5/26/22

Today's Change+0.07(4.67%)
Bid (Size)$1.47 (11)
Ask (Size)$1.58 (95)
Day Low / High$1.50 - 1.59
Volume494.4 K

Insider Buy: Outlook Therapeutics

6:18AM ET 12/02/2021 MT Newswires
Ghiath M. Sukhtian, 10% Owner, Director, on November 29, 2021, executed a purchase for 16,000,000 shares in Outlook Therapeutics (OTLK) for $20,000,000. Following the Form 4 filing with the SEC, Sukhtian has control over a total of 78,799,315 shares of the company, with 78,799,315 controlled indirectly. The market value of the direct and indirect holding, based on the transaction price, is approximately $98,499,144.

SEC Filing:


Price: 1.42, Change: +0.13, Percent Change: +0.1